[1]谭勇川,唐茂怀.癌痛患者的不同滴定策略对比分析[J].医学信息,2019,32(03):110-112.[doi:10.3969/j.issn.1006-1959.2019.03.034]
　TAN Yong-chuan,TANG Mao-huai.Comparative Analysis of Different Titration Strategies for Patients with Cancer Pain[J].Journal of Medical Information,2019,32(03):110-112.[doi:10.3969/j.issn.1006-1959.2019.03.034]
点击复制

癌痛患者的不同滴定策略对比分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年03期
页码:
110-112
栏目:
临床研究
出版日期:
2019-02-01

文章信息/Info

Title:
Comparative Analysis of Different Titration Strategies for Patients with Cancer Pain
文章编号:
1006-1959（2019）03-0110-03
作者:
谭勇川1; 唐茂怀2
（1.川北医学院第二附属医院肿瘤科，四川 南充 637000；2.南充卫生学校附属医院妇产科，四川 南充 637000）
Author(s):
TAN Yong-chuan1; TANG Mao-huai2
(1.Department of Oncology,the Second Affiliated Hospital of North Sichuan Medical College, Nanchong 637000,Sichuan,China;2.Department of Obstetrics and Gynecology,Affiliated Hospital of Nanchong Health School, Nanchong 637000,Sichuan,China)
关键词:
癌痛; 吗啡; 滴定; 用药依从性; 不良反应
Keywords:
Cancer pain; Morphine; Titration; Medication compliance; Adverse reactions
分类号:
R730.53
DOI:
10.3969/j.issn.1006-1959.2019.03.034
文献标志码:
A
摘要:
目的 观察中重度癌痛治疗中不同滴定策略的效果，为临床中重度癌痛患者选择较优滴定方案。方法 选取我院2014年12月~2017年6月接受治疗的120例中重度癌痛患者，随机分为A组、B组和C组，每组40例。A组患者使用即释吗啡片5 mg q4h作为初始剂量滴定治疗；B组、C组患者分别使用盐酸吗啡缓释片10 mg、20 mg q12h作为初始剂量治疗。各组滴定至显效后即改为足量盐酸吗啡缓释片维持治疗。观察三组滴定显效时间、用药依从性、主要不良反应及平均初始日费用。结果 给药后A、B、C三组滴定显效时间分别为（1.53±0.96） d、（4.13±1.71）d和（2.76±0.81）d，差异有统计学意义（P＜0.05）。A、B、C三组患者的用药依从性分别为35.00%、90.00%和60.00%，差异有统计学意义（P＜0.05）。主要不良反应表现：B组便秘发生率为13.00%，低于A组的20.00%和C组的53.00%，差异有统计学意义（P＜0.05）；B组头晕发生率为3.00%，低于A组的23.00%和C组的28.00%，差异有统计学意义（P＜0.05）。A、B、C三组平均初始日费用分别为（39.5±17.13）元、（55.25±27.43）元和（65.13±27.07）元，差异有统计学意义（P＜0.05）。结论 以10 mg盐酸吗啡缓释片为初始剂量治疗中、重度癌痛患者显效时间稍长，但具有良好的用药依从性，不良反应较轻，容易管理，价格适中，是基层医院首选的滴定药物之一。
Abstract:
Objective To observe the effect of different titration strategies in the treatment of moderate to severe cancer pain, and to select a better titration scheme for patients with severe cancer pain in the clinic. Methods A total of 120 patients with moderate to severe cancer pain who were treated in our hospital from December 2014 to June 2017 were randomly divided into group A, group B and group C, with 40 cases in each group. Patients in group A were treated with immediate release morphine tablets 5 mg q4h as initial dose titration; patients in group B and C were treated with morphine hydrochloride sustained release tablets 10 mg and 20 mg q12h as initial doses. After titration to significant effect, each group was changed to a sufficient amount of morphine hydrochloride sustained-release tablets for maintenance treatment. Three groups of titration time, medication compliance, major adverse reactions, and average initial day cost were observed. Results The effective time of titration in group A, B and C was (1.53±0.96) d, (4.13±1.71) d and (2.76±0.81) d, respectively,the difference was statistically significant (P<0.05). The medication compliance of the three groups A, B, and C were 35.00%, 90.00%, and 60.00%, respectively,the difference was statistically significant (P<0.05). The main adverse reactions: the incidence of constipation in group B was 13.00%, which was lower than 20.00% in group A and 53.00% in group C,the difference was statistically significant (P<0.05). The incidence of dizziness in group B was 3.00%,Less than 23.00% in Group A and 28.00% in group C, the difference was statistically significant (P<0.05). The average initial daily expenses of the three groups A, B and C were (39.5±17.13) yuan, (55.25±27.43) yuan and (65.13±27.07) yuan, the difference was statistically significant (P<0.05). Conclusion The 10 mg morphine hydrochloride sustained-release tablets as the initial dose for the treatment of patients with moderate to severe cancer pain has a slightly longer time, but has good medication compliance, mild adverse reactions, easy management, and moderate price. It is one of the preferred titration drugs for primary hospitals.

参考文献/References:


[1]Imanaka K,Tominaga Y,Etropolski M,et al.Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release[J].Clin Drug Investig,2014,34(7):501-511.
[2]Wiffen PJ,Wee B,Derry S,et al.Opioids for cancer pain--an overview of Cochrane reviews[J].Cochrane Database Syst Rev,2017(6):CD012592.
[3]Robert Twycross.Introducing Pallitive Care[M].第5版.李金祥,译.北京:人民卫生出版社,2017:90.
[4]Juba KM,Khadem TM,Hutchinson DJ,et al.Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study[J].J Palliat Med,2017,20(7):722-728.
[5]Anghelescu DL,Patel RM,Mahoney DP,et al.Methadone prolongs cardiac conduction inyoung patients with cancer-related pain[J].J Opioid Manag,2016,12(2):131-138.
[6]Isbister GK,Brown AL,Gill A,et al.QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings[J].Br J Clin Pharmacol,2017,83(10):2274-2282.
[7]于世英,邱红,马振山,等.盐酸吗啡缓释片治疗癌症疼痛的临床疗效分析[J].中华医学杂志,2004(6):14-19.
[8]Hammig R,Kohler W,Bonorden-Kleij K,et al.Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence[J].J Subst Abuse Treat,2014,47(4):275-281.
[9]NCCN.PracticeGudelines in Adult Cancer Pain[S].V.2.2017.
[10]程凯,蔡红,魏阳,等.盐酸羟考酮缓释片与盐酸吗啡缓释片治疗中度癌痛回顾性分析[J].中国药师,2014,17(7):1170-1172.

相似文献/References:

[1]缪继东.盐酸吗啡缓释片联合低剂量阿米替林治疗中重度癌性骨痛的疗效观察[J].医学信息,2018,31(21):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
　MIAO Ji-dong.Effects of Morphine Hydrochloride Sustained-release Tablets Combined with Low Dose Amitriptyline in the Treatment of Moderate and Severe Cancer Bone Pain[J].Journal of Medical Information,2018,31(03):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
[2]张 露,刘 铭,彭玉龙,等.盐酸羟考酮缓释片对急性放射性黏膜炎所致疼痛的应用效果评价[J].医学信息,2019,32(08):148.[doi:10.3969/j.issn.1006-1959.2019.08.045]
　ZHANG Lu,LIU Ming,PENG Yu-long,et al.Evaluation of the Effect of Oxycodone Hydrochloride Sustained-release Tablets on Pain Caused by Acute Radiation Mucositis[J].Journal of Medical Information,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.08.045]
[3]郭占芳,张红武,杨如意,等.益气滋阴通腑方对吗啡所致便秘小鼠肠道传输功能的影响[J].医学信息,2019,32(09):156.[doi:10.3969/j.issn.1006-1959.2019.09.052]
　GUO Zhan-fang,ZHANG Hong-wu,YANG Ru-yi,et al.Effect of Yiqi Ziyin Tongfu Recipe on Intestinal Transmission Function of Constipation-induced Constipation in Mice[J].Journal of Medical Information,2019,32(03):156.[doi:10.3969/j.issn.1006-1959.2019.09.052]
[4]卡地尔丁·艾海提,叶建荣.吗啡不同给药时机对硬膜外麻醉下行剖宫产术患者的麻醉效果及术后镇痛效果的影响[J].医学信息,2022,35(16):51.[doi:10.3969/j.issn.1006-1959.2022.16.011]
　KADIERDING·AIHAITI,YE Jian-rong.Effects of Different Administration Time of Morphine on Anesthesia and Postoperative Analgesia in Patients Undergoing Cesarean Section Under Epidural Anesthesia[J].Journal of Medical Information,2022,35(03):51.[doi:10.3969/j.issn.1006-1959.2022.16.011]
[5]陆玲芳,朱菊娥.标准化电话随访模式在癌痛患者延伸护理中的应用[J].医学信息,2020,33(10):179.[doi:10.3969/j.issn.1006-1959.2020.10.056]
　LU Ling-fang,ZHU Ju-e.Application of Standardized Telephone Follow-up Mode in Extended Care for Patients with Cancer Pain[J].Journal of Medical Information,2020,33(03):179.[doi:10.3969/j.issn.1006-1959.2020.10.056]
[6]孙思宁,哈敏文.定期微信回访对癌痛门诊患者镇痛效果的影响[J].医学信息,2020,33(10):126.[doi:10.3969/j.issn.1006-1959.2020.10.036]
　SUN Si-ning,HA Min-wen.The Effect of Regular WeChat Follow-up Visits on the Analgesic Effect of Outpatients with Cancer Pain[J].Journal of Medical Information,2020,33(03):126.[doi:10.3969/j.issn.1006-1959.2020.10.036]
[7]罗尔丹,卞 鹰.基于在线医疗平台的癌痛患者医疗服务需求分析[J].医学信息,2021,34(03):1.[doi:10.3969/j.issn.1006-1959.2021.03.001]
　LUO Er-dan,BIAN Ying.Analysis of Medical Service Demands for Cancer Pain Patients Based on Online Medical Platform[J].Journal of Medical Information,2021,34(03):1.[doi:10.3969/j.issn.1006-1959.2021.03.001]
[8]刘 婷,马 丽,朱红英,等.简化McGill疼痛问卷用于肺癌癌痛综合评定的研究[J].医学信息,2021,34(03):6.[doi:10.3969/j.issn.1006-1959.2021.03.002]
　LIU Ting,MA Li,ZHU Hong-ying,et al.Study on the Simplified McGill Pain Questionnaire for Comprehensive Assessment of Lung Cancer Pain[J].Journal of Medical Information,2021,34(03):6.[doi:10.3969/j.issn.1006-1959.2021.03.002]
[9]杨春霞,江期华.盐酸羟考酮缓释片与硫酸吗啡缓释片治疗阿片未耐受患者中、重度癌痛的效果比较[J].医学信息,2022,35(22):133.[doi:10.3969/j.issn.1006-1959.2022.22.031]
　YANG Chun-xia,JIANG Qi-hua.Comparison of Oxycodone Hydrochloride Sustained-release Tablets and Morphine Sulfate Sustained-release Tablets in the Treatment of Moderate and Severe Cancer Pain in Patients with Opioid Intolerance[J].Journal of Medical Information,2022,35(03):133.[doi:10.3969/j.issn.1006-1959.2022.22.031]
[10]黄 辉,李元海,周 磊,等.吗啡复合布比卡因用于收肌管阻滞在全膝关节置换术后镇痛的效果[J].医学信息,2021,34(16):172.[doi:10.3969/j.issn.1006-1959.2021.16.049]
　HUANG Hui,LI Yuan-hai,ZHOU Lei,et al.Effect of Morphine Combined with Bupivacaine for Analgesia of Adductor Tube Block After Total Knee Arthroplasty[J].Journal of Medical Information,2021,34(03):172.[doi:10.3969/j.issn.1006-1959.2021.16.049]

更新日期/Last Update: 2019-02-25